MIUDELLA®

About Sebela Pharmaceuticals

Sebela Pharmaceuticals is a private, commercial-stage biopharmaceutical company founded in 2014 and headquartered in Braintree, Massachusetts. The company operates with a dual focus: maintaining a leading position in the gastroenterology market through its affiliate Braintree and driving innovation in women's health via its Sebela Women's Health division. Its near-term value drivers include the FDA review of tegoprazan for GERD and the recent licensing of its hormone-free IUD, MIUDELLA®, to Organon, while its pipeline suggests a commitment to sustained growth in its core therapeutic areas.

Therapeutic Areas